Access to generic antiretroviral drugs overshadows the International AIDS Conference. Leaders in the fight against AIDS urge the United States to fast-track approval of Indian-made three-in-one generic drugs, but some are skeptical of the FDA's role.
http://www.wired.com/news/medtech/0,...tml?tw=rss.TEK